Voluntary Nature Of Adverse Event Reporting Is Flaw In System - Kennedy
One of the main criticisms that can be leveled against FDA's Medwatch program is that it is a voluntary system, Senate Health Committee Ranking Minority Member Kennedy (D-Mass.) said Feb. 24 at a Drug Information Association meeting in Washington, D.C.
You may also be interested in...
Senate Labor/HHS Appropriations Subcommittee Chairman Specter (R-Penn.) is planning a hearing to discuss recommendations outlined in a Nov. 29 Institute of Medicine report on medical errors and patient safety.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011